Leal Awarded R01 to Study Secondary Mold Infection in COVID Patients

Sixto Leal, Jr., M.D., Ph.D., Associate Professor, Laboratory Medicine, UAB Pathology, has been awarded a 4-year, $2.97 million R01 grant from the National Institute of Allergy and Infectious Diseases to study secondary mold infections in patients with severe viral infections, such as COVID. These mold infections, if not recognized or treated, can be fatal. The grant, titled, “The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity,” runs through July 2027.

Read the full story here.

Leave a Reply

Your email address will not be published. Required fields are marked *